SCHEMBL8440676

SCHEMBL8440676

CCCCCCCCCC/C=C/C(C)=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.58
FASN P49327 1/20 0.57
PPARG P37231 5/20 0.56
PPARA Q07869 5/20 0.56
TERT O14746 3/20 0.55
PPARD Q03181 3/20 0.55
CYP1A2 P05177 2/20 0.55
MAPT P10636 2/20 0.55
CYP2C19 P33261 2/20 0.55
BLM P54132 2/20 0.55
HSD17B10 Q99714 2/20 0.55
FABP4 P15090 2/20 0.55
FAAH O00519 2/20 0.55
KMT2A Q03164 2/20 0.55
GMNN O75496 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8443714 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8441219 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8444866 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL1129290 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL6903523 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL1129945 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL6903526 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8441217 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL8440536 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT
SCHEMBL1491161 1.00 PTPN1 (0.58) PTPN1FASNPPARGPPARATERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339174-B2 γ-spiroketal-γ-lactones and pharmaceutical composition containing same and process for preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-05-24 US claimed
US-11076600-B2 Mixtures of cis-jasmone and bacillus amyloliquefaciens BASF SE (DE) 2021-08-03 US claimed
US-20210198273-A1 GAMMA-SPIROKETAL-GAMMA-LACTONES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-07-01 US claimed
EP-3619214-A1 GAMMA-SPIROKETAL-GAMMA-LACTONES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PROCESS FOR PREPARATION THEREOF Council of Scientific and Industrial Research (IN) 2020-03-11 EP claimed
US-20180317498-A1 Mixtures of Cis-Jasmone and Bacillus Amyloliquefaciens BASF SE (DE) 2018-11-08 US claimed
WO-2018203346-A1 γ-SPIROKETAL- γ –LACTONES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-11-08 WO claimed
JP-6239705-A None JP disclosed
US-20260101887-A1 AN EMULSIFIABLE CONCENTRATE HAVING A LACTONE-BASED SOLVENT SYSTEM BASF SE (DE) 2026-04-16 US disclosed
WO-2025242698-A1 AN OIL-IN-WATER EMULSION-BASED AGROCHEMICAL FORMULATION BASF SE (DE) 2025-11-27 WO disclosed
WO-2025233453-A1 NEW AGROCHEMICAL FORMULATIONS BASF SE (DE) 2025-11-13 WO disclosed
WO-2025233452-A1 CROP PROTECTION COMPOSITIONS WITH AMIDE/GVL SOLVENT SYSTEM BASF SE (DE) 2025-11-13 WO disclosed
EP-4598348-A1 AN EMULSIFIABLE CONCENTRATE HAVING A LACTONE-BASED SOLVENT SYSTEM BASF SE (DE) 2025-08-13 EP disclosed
WO-2025093527-A1 AN EMULSIFIABLE CONCENTRATE HAVING AN AMIDE/ESTER/CO-SOLVENT SOLVENT SYSTEM BASF SE (DE) 2025-05-08 WO disclosed
EP-0814660-B1 TOPICAL ANTIMICROBIAL AGENTS RES CORP TECHNOLOGIES INC (US) 1999-06-23 EP disclosed
EP-0814660-A1 TOPICAL ANTIMICROBIAL AGENTS Research Corporation Technologies, Inc (US) 1998-01-07 EP disclosed
US-5610196-A METHYL UNSATURATED LONG-CHAIN ALKYL KETONE, ACNE RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-03-11 US disclosed
US-5604262-A UNSATURATED ALKYL KETONE RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-02-18 US disclosed
WO-1996028975-A1 TOPICAL ANTIMICROBIAL AGENTS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1996-09-26 WO disclosed
JP-H06239705-A SEX ATTRACTANT FOR ASIATIC BEETLE NORIN SUISANSYO SANSHI KONCHIYUU NOGYO GIJUTSU KENKYUSHO 1994-08-30 JP disclosed
US-4393245-A 1-ACETYL-1-CYCLODODECENE BASF AKTIENGESELLSCHAFT (DE) 1983-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11076600-B2 Mixtures of cis-jasmone and bacillus amyloliquefaciens BAX, FASN, BAK1 PTPN1 2607/4885FASN 2/4885PPARG 223/4885
US-20180317498-A1 Mixtures of Cis-Jasmone and Bacillus Amyloliquefaciens BAX, FASN, BAK1 PTPN1 2607/4885FASN 2/4885PPARG 223/4885
US-11339174-B2 γ-spiroketal-γ-lactones and pharmaceutical composition containing same and process for preparation thereof HSD17B7, PKD1, CYP17A1 PTPN1 3648/4885FASN 2179/4885PPARG 467/4885
US-20260101887-A1 AN EMULSIFIABLE CONCENTRATE HAVING A LACTONE-BASED SOLVENT SYSTEM HACL2, CWC22, DHCR7 PTPN1 1199/4885FASN 1008/4885PPARG 688/4885
US-20210198273-A1 GAMMA-SPIROKETAL-GAMMA-LACTONES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PROCESS FOR PREPARATION THEREOF HSD17B7, PKD1, CYP17A1 PTPN1 3775/4885FASN 2060/4885PPARG 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.